Table 1: Baseline characteristics.
|
|
Overall n.39 |
Group A. n.28 |
Group B. n.11 |
P |
|||||
Gender (male)(%) |
|
30(76.9) |
20(71.4) |
10(90.9) |
0.19 |
|||||
Age (m)(IQR) |
|
29.5(22-36) |
27(22-30) |
35.9(24-44) |
0.11 |
|||||
Pervious dialysis history (%) |
|
38(97.4) |
27(96.4) |
11(100) |
0.8 |
|||||
PD (%) |
|
11(28.2) |
9(32.2) |
3(27.3) |
|
|||||
HD (%) |
|
27(69.2) |
19(67.8) |
8(72.7) |
|
|||||
Dialytic therapy (months)(m)(IQR) |
|
37(11.7-48) |
26.4(11-26) |
63(12-84) |
0.22 |
|||||
Residual urine output (%) |
|
20(51.3) |
16(57.1) |
4(36.4) |
0.24 |
|||||
Type of Donor |
|
|
|
|
0.057 |
|||||
BDD (%) |
|
18(46.2) |
10(35.7) |
8(72.7) |
|
|||||
RLD (%) |
|
21(53.8) |
18(64.3) |
3(27.3) |
|
|||||
Cold Ischemia (min) (m)(IQR) |
|
127(60-188) |
119.1(60-142) |
150.3(65-234) |
0.16 |
|||||
Hot Ischemia (min) (m)(IQR) |
|
6.7(3-7) |
6.6(3-6.7) |
6.8(3-9) |
1 |
|||||
Hb g/dl (m)(IQR) |
|
11(9.6-12.3) |
11.3(9-12) |
10.4(7.8-12.2) |
0.43 |
|||||
Serum glucose mg/dl (m)(IQR) |
|
91.9(82.7-97) |
92(83-97) |
91.7(81-97) |
0.97 |
|||||
Urea mg/dl (m)(IQR) |
|
136(99.6-171) |
136.4(94-170) |
137(104-172) |
0.77 |
|||||
Creatinine mg/dl (m)(IQR) |
|
12.9(9.5-16.7) |
12.6(8.7-17) |
13.7(10.2-16.7) |
0.31 |
|||||
Sodio mg/dl (m)(IQR) |
|
136(134-138) |
136.6(135-138) |
134(132-136) |
0.03* |
|||||
Phosphorus mg/dl (m)(IQR) |
|
5.7(3.8-7.1) |
5.6(3.5-7) |
5.9(4.1-7.9) |
0.9 |
|||||
Potassium mg/dl (m)(IQR) |
|
48(4.1-5.4) |
4.9(4-5.6) |
4.8(4.5-5.4) |
0.54 |
|||||
Calcio mg/dl (m)(IQR) |
|
89(8.3-7.1) |
8.8(8.2-9.6) |
9.3(8.2-10.3) |
0.33 |
|||||
Baseline characteristics prior kidney transplantation |
|
|
|
|
||||||
U Mann-whitney test, chi square, p = 0.05* |
|
|
|
|